Driving innovative drug discovery through integrated high-throughput screening platform

DOWNLOAD： Presentation document

Description：

High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug discovery. The innovative technologies for drugging undruggable targets and IPS cells have been shed new light on small molecule drug discovery. Axcelead has diverse and high-quality compound libraries and provides comprehensive hit/lead finding services including both target and phenotype based drug discovery. Dr. Kawamoto will demonstrate how Axcelead could successfully discover hit/lead compounds with our cutting edge technologies and multidisciplinary strategies. Moreover, you can learn about our capability on drugging undruggable targets such as RNA targeted drug discovery, Protein degraders and phenotypic screening using IPS cells. Axcelead accelerates your innovation.